A detailed history of Silicon Valley Community Foundation transactions in Guardant Health, Inc. stock. As of the latest transaction made, Silicon Valley Community Foundation holds 13,399 shares of GH stock, worth $433,591. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,399
Previous 13,599 1.47%
Holding current value
$433,591
Previous $280,000 37.86%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$16.07 - $31.84 $3,214 - $6,368
-200 Reduced 1.47%
13,399 $386,000
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $3,802 - $5,974
-222 Reduced 1.61%
13,599 $280,000
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $5,071 - $6,932
-235 Reduced 1.67%
13,821 $374 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $6,966 - $10,791
-270 Reduced 1.88%
14,056 $417 Million
Q2 2023

Nov 14, 2023

SELL
$20.94 - $38.01 $6,156 - $11,174
-294 Reduced 2.01%
14,326 $513 Million
Q1 2023

Nov 14, 2023

SELL
$22.92 - $33.76 $7,861 - $11,579
-343 Reduced 2.29%
14,620 $343 Million
Q3 2022

Nov 14, 2023

SELL
$43.66 - $61.0 $12,268 - $17,141
-281 Reduced 1.84%
14,963 $805 Million
Q2 2022

Nov 14, 2023

SELL
$28.82 - $77.35 $6,340 - $17,017
-220 Reduced 1.42%
15,244 $615 Million
Q1 2022

Nov 14, 2023

SELL
$48.25 - $100.49 $10,373 - $21,605
-215 Reduced 1.37%
15,464 $1.02 Billion
Q4 2021

Nov 14, 2023

SELL
$88.71 - $120.43 $23,330 - $31,673
-263 Reduced 1.65%
15,679 $1.57 Billion
Q3 2021

Nov 14, 2023

SELL
$98.77 - $132.17 $25,482 - $34,099
-258 Reduced 1.59%
15,942 $1.99 Billion
Q4 2020

Nov 14, 2023

BUY
$99.96 - $135.93 $1.62 Million - $2.2 Million
16,200 New
16,200 $2.09 Billion

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.31B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Silicon Valley Community Foundation Portfolio

Follow Silicon Valley Community Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Community Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Community Foundation with notifications on news.